196 related articles for article (PubMed ID: 10665277)
1. [Clinical and pathogenetic features of neurotrophic corneal disorders in diabetes].
Didenko TN; Smoliakova GP; Sorokin EL; Egorov VV
Vestn Oftalmol; 1999; 115(6):7-11. PubMed ID: 10665277
[TBL] [Abstract][Full Text] [Related]
2. [The cornea of diabetics].
Ben Osman N; Jeddi A; Sebai L; Zghal I; Kaoueche M; Gaigi S; Ayed S
J Fr Ophtalmol; 1995; 18(2):120-3. PubMed ID: 7738303
[TBL] [Abstract][Full Text] [Related]
3. Blinking and superficial punctate keratopathy in patients with diabetes mellitus.
Inoue K; Okugawa K; Amano S; Oshika T; Takamura E; Egami F; Umizu G; Aikawa K; Kato S
Eye (Lond); 2005 Apr; 19(4):418-21. PubMed ID: 15286669
[TBL] [Abstract][Full Text] [Related]
4. Corneal structure and sensitivity in type 1 diabetes mellitus.
Rosenberg ME; Tervo TM; Immonen IJ; Müller LJ; Grönhagen-Riska C; Vesaluoma MH
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2915-21. PubMed ID: 10967045
[TBL] [Abstract][Full Text] [Related]
5. Dr. P. Siva Reddy Oration. Diabetic keratopathy.
Rao GN
Indian J Ophthalmol; 1987; 35(5-6):16-36. PubMed ID: 3508767
[TBL] [Abstract][Full Text] [Related]
6. [Corneal sensitivity in diabetes mellitus].
Riss B; Binder S; Havelec L
Klin Monbl Augenheilkd; 1982 Jun; 180(6):553-5. PubMed ID: 7132182
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the corneal surface in limbal stem cell deficiency and after transplantation of cultivated limbal epithelium.
Pauklin M; Steuhl KP; Meller D
Ophthalmology; 2009 Jun; 116(6):1048-56. PubMed ID: 19394701
[TBL] [Abstract][Full Text] [Related]
8. [Diabetic keratopathy: new progresses and challenges].
Wang Y; Zhou Q; Xie L
Zhonghua Yan Ke Za Zhi; 2014 Jan; 50(1):69-72. PubMed ID: 24709136
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus and the rabbit corneal epithelium.
Friend J; Kiorpes TC; Thoft RA
Invest Ophthalmol Vis Sci; 1981 Aug; 21(2):317-21. PubMed ID: 7251310
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic keratopathy and diabetes mellitus.
Lockwood A; Hope-Ross M; Chell P
Eye (Lond); 2006 Jul; 20(7):837-9. PubMed ID: 16215544
[TBL] [Abstract][Full Text] [Related]
11. Discoveries in research on diabetic keratopathy.
Cisarik-Fredenburg P
Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
[TBL] [Abstract][Full Text] [Related]
12. The cornea in diabetes mellitus.
Sánchez-Thorin JC
Int Ophthalmol Clin; 1998; 38(2):19-36. PubMed ID: 9604736
[TBL] [Abstract][Full Text] [Related]
13. Tear production and corneal sensitivity in diabetes.
Cousen P; Cackett P; Bennett H; Swa K; Dhillon B
J Diabetes Complications; 2007; 21(6):371-3. PubMed ID: 17967709
[TBL] [Abstract][Full Text] [Related]
14. Neuronal Changes in the Diabetic Cornea: Perspectives for Neuroprotection.
Bikbova G; Oshitari T; Baba T; Yamamoto S
Biomed Res Int; 2016; 2016():5140823. PubMed ID: 28044131
[TBL] [Abstract][Full Text] [Related]
15. Profile of cytokines in aqueous humor from corneal graft recipients.
Dekaris I; Gabrić N; Mazuran R; Karaman Z; Mravicić I
Croat Med J; 2001 Dec; 42(6):650-6. PubMed ID: 11740849
[TBL] [Abstract][Full Text] [Related]
16. Recurrent corneal erosion: pathogenesis and therapy.
Kenyon KR
Int Ophthalmol Clin; 1979; 19(2):169-95. PubMed ID: 110716
[No Abstract] [Full Text] [Related]
17. Detection and regulation of cationic amino acid transporters in healthy and diseased ocular surface.
Jäger K; Bönisch U; Risch M; Worlitzsch D; Paulsen F
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1112-21. PubMed ID: 18997084
[TBL] [Abstract][Full Text] [Related]
18. Is intraocular pressure in myotonic dystrophy patients spuriously low?
Kesler A; Berkner L; Sadeh M; Levite R; Varssano D
Isr Med Assoc J; 2008 Oct; 10(10):699-701. PubMed ID: 19009949
[TBL] [Abstract][Full Text] [Related]
19. Autologous serum application in the treatment of neurotrophic keratopathy.
Matsumoto Y; Dogru M; Goto E; Ohashi Y; Kojima T; Ishida R; Tsubota K
Ophthalmology; 2004 Jun; 111(6):1115-20. PubMed ID: 15177961
[TBL] [Abstract][Full Text] [Related]
20. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
